Tci Wealth Advisors, Inc. Seagen Inc. Transaction History

Tci Wealth Advisors, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	BUY	$127.59 - $203.08 $3,700 - $5,889	29 Added 1450.0%	31 $6,000
Q4 2022 Feb 06, 2023	SELL	$117.37 - $139.17 $234 - $278	-2 Reduced 50.0%	2 $0
Q3 2022 Nov 08, 2022	BUY	$135.27 - $180.11 $405 - $540	3 Added 300.0%	4 $1,000
Q1 2022 Apr 29, 2022	SELL	$119.61 - $157.85 $8,851 - $11,680	-74 Reduced 98.67%	1 $0
Q4 2021 Jan 24, 2022	SELL	$142.57 - $190.86 $285 - $381	-2 Reduced 2.6%	75 $12,000
Q3 2021 Oct 29, 2021	BUY	$142.45 - $169.82 $6,410 - $7,641	45 Added 140.63%	77 $13,000
Q2 2021 Aug 02, 2021	SELL	$135.08 - $161.1 $2,026 - $2,416	-15 Reduced 31.91%	32 $5,000
Q1 2021 Apr 29, 2021	BUY	$137.51 - $190.8 $6,462 - $8,967	47 New	47 $7,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.